Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5608
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan ; day:10 ; month:10 ; year:2022 ; pages:1-2
Prostate cancer and prostatic diseases ; (10.10.2022), 1-2
- Urheber
-
Shao, Yu-Hsuan Joni
Hong, Jian-Hua
Chen, Chun-Kai
Huang, Chao-Yuan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41391-022-00596-5
- URN
-
urn:nbn:de:101:1-2022122721143533627289
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shao, Yu-Hsuan Joni
- Hong, Jian-Hua
- Chen, Chun-Kai
- Huang, Chao-Yuan
- SpringerLink (Online service)
Ähnliche Objekte (12)
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
Effekt eines Gonadotropin-Releasing-Hormon Agonisten auf die Prolaktinsekretion
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Der Einfluss von Gonadotropin-Releasing-Hormone-Agonisten-Therapie auf den Knochenstoffwechsel von Frauen
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
Effekte eines Gonadotropin-Releasing-Hormon-Agonisten auf die Sekretion der Gonadotropine bei jungen Männern
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
Effekt eines Gonadotropin-Releasing-Hormon Agonisten auf die Prolaktinsekretion
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Der Einfluss von Gonadotropin-Releasing-Hormone-Agonisten-Therapie auf den Knochenstoffwechsel von Frauen
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
Effekte eines Gonadotropin-Releasing-Hormon-Agonisten auf die Sekretion der Gonadotropine bei jungen Männern
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
Effekt eines Gonadotropin-Releasing-Hormon Agonisten auf die Prolaktinsekretion
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Der Einfluss von Gonadotropin-Releasing-Hormone-Agonisten-Therapie auf den Knochenstoffwechsel von Frauen
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients